Submission status for AMGEN INC's drug REPATHA (SUPPL-47) with active ingredient EVOLOCUMAB has changed to 'Approval' on 10/09/2026. Application Category: BLA, Application Number: 125522, Application Classification:
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
3 - Vertical Aerospace Ltd. (0001867102) (Issuer)
3/A - KLX Energy Services Holdings, Inc. (0001738827) (Issuer)
4 - OneMedNet Corp (0001849380) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - OneMedNet Corp (0001849380) (Issuer)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
4 - Bluerock Private Real Estate Fund (0001551047) (Issuer)
4 - UL Solutions Inc. (0001901440) (Issuer)
4 - INNSUITES HOSPITALITY TRUST (0000082473) (Issuer)
4 - MediaAlpha, Inc. (0001818383) (Issuer)
4 - Marvell Technology, Inc. (0001835632) (Issuer)
4 - BETA Technologies, Inc. (0001784570) (Issuer)
